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ABSTRACT
This study assessed the clinical effects and the 
mechanical antinociceptive potential of intravenous (IV) tramadol 
in horses.A blinded and randomized study was designed with 7 
horses treated with 1 (Tr1), 2 (Tr2) or 3 (Tr3) mg kg-1 of tramadol 
IV. The heart rate, respiratory rate (fR), arterial pressure, degree of 
sedation, gastrointestinal motility (GI), behavior changes and the 
mechanical nociceptive threshold (MNT) were evaluated. The MNT 
was determined with von Frey device method.Tr3 had a signifi cant 
increase in their fR and more pronounced behavioral changes than 
other treatments.The Tr1 showed a signifi cant increase in arterial 
pressure. The GI reduced signifi cantly, mainly in Tr2. The tramadol 
did not change the MNT of the horses.The clinical alterations 
observed with the different treatments were considered mild and 
transitory, being most evident in Tr2. However the tramadol did 
not have any analgesic effect with any of the doses evaluated.
Keywords: analgesia, horse, opioid, von Frey device.
RESUMO
Avaliaram-se os efeitos clínicos e o potencial 
antinociceptivo mecânico de diferentes doses de tramadol 
administradas por via intravenosa (IV) em equinos. Sete 
animais foram tratados com 1 (Tr1), 2 (Tr2) ou 3 (Tr3) mg 
kg-1de tramadol IV em um estudo cruzado do tipo cego e 
randomizado. Foram avaliados frequência cardíaca, frequência 
respiratória, temperatura retal, pressão arterial, nível de sedação, 
motilidade gastrointestinal, alterações comportamentais e limiar 
antinociceptivo mecânico (Von Frey). As principais alterações 
evidenciadas pela administração do tramadol concentram-se no 
aumento na frequência respiratória em Tr3, aumento signifi cativo 
da pressão arterial em Tr1 e redução da motilidade gastrointestinal, 
mais pronunciada em Tr2. O tramadol não promoveu alteração 
signifi cativa no limiar nociceptivo mecânico. As alterações clínicas 
observadas nos diferentes tratamentos foram consideradas leves 
e transitórias. Diante dos resultados, pode-se concluir que o 
tramadol não apresentou efeito antinociceptivo passível de ser 
avaliado pelo método empregado no presente estudo, em nenhum 
dos tratamentos.
Palavras-chave: analgesia, equino, opioide, von Frey.
INTRODUCTION
Although it is extensively used to control 
light and moderate pain in humans, the use of tramadol 
in veterinary patients is relatively recent (NATALINI 
& ROBINSON, 2000). In horses, tramadol is quickly 
metabolized mainly into N-desmethyltramadol (M2), 
which is pharmacologically inactive, and its clinical 
effi ciency is unclear in this species as compared to 
humans (GIORGI et al., 2007). It is believed that the 
analgesic effects of tramadol can be associated with 
other mechanisms of action, such as the modulation 
of the serotoninergic and monoaminergic pathways 
(NATALINI& ROBINSON, 2000; DHANJAL et al., 
2009; KNYCH et al., 2013). 
The route of administration of the 
tramadol in horses and the model of nociceptive 
stimulation seem to infl uence the observed analgesic 
effects. When a 2mg kg-1 dose was administered by 
epidural injection, with no nociceptive evaluation, 
the drug produced plasma concentrations >100ng 
mL-1; if it was extrapolated to human beings, 
such concentrations would be enough to achieve 
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signifi cant analgesia (GIORGI et al., 2010). Recently, 
KNYCH et al. (2013) observed plasma tramadol 
concentrations greater than those necessary for 
analgesia in human patients for doses of 0.5 to 3.0mg 
kg-1 in horses. NATALINI & ROBINSON (2000), 
when evaluating the analgesic effects of tramadol after 
the administration of 1mg kg-1 by epidural injection, 
observed the presence of a signifi cant analgesia to 
electrical stimulation comparable to that provided 
by morphine. As for intravenous injection, a original 
study that used a 2mg kg-1 dose of tramadol did not 
reveal analgesic effects in healthy horses subjected to 
thermal stimulation (DHANJAL et al., 2009). 
Pressure algometry, through mechanical 
stimulation, is repeatable and provides quantitative 
information on nociception (HAUSSLER & ERB, 
2006). One method, von Frey fi laments, described 
by Maximilian von Frey in 1896, has been used with 
relative safety and repeatability for the evaluation 
of cutaneous sensitivity in horses (REDUA et 
al., 2002; OLESKOVICZ et al., 2006) and dogs 
(DUQUE et al., 2004, KUKANICH & PAPICH, 
2011). As an alternative to the von Frey fi laments, 
electronic methods have been developed and tested 
on other species (CUNHA et al., 2004; DENADAI-
SOUZA et al., 2009) and showed advantages over the 
classic method, including a reduction in the number 
of attempts required to evaluate the nociceptive 
threshold, the elimination of problems in the 
standardization of the fi laments.
The objectives of this study were to 
evaluate the clinical and cardiorespiratory effects 
and the antinociceptive mechanic potential of 
three different doses of tramadol administered 
intravenously in horses. It was hypothesized that 
tramadol would have antinoceptive effects in horses 
undergoing mechanical stimulation.
MATERIAL   AND   METHODS
The experiment was conducted after its 
approval by the institutional animal care and use 
committee.Seven healthy mixed-breed adult horses 
of either sex, aged 9-13 years old and weighing 
318±36kg, were used in the study. The horses 
were deemed to be healthy on the basis of physical 
examination and standard laboratory tests. 
The horses were acclimated by daily 
restraint in the stocks, for 15 days before the 
beginning of the experiment. The sequence of 
treatments for each animal was randomly determined 
taking care that each animal was not allocated to the 
same treatment more than once. The evaluators were 
blinded to the sequence of treatments until the end 
of the experiment.Each horse was studied on three 
occasions using a randomized crossover design, with 
a minimum of 15 days between experiments.
Tramadol hydrochloride 5%a was prepared 
with a fi nal concentration of 10mg mL-1 of tramadol 
in saline solution and infused over 10 minutes from a 
syringe pumpb. The horses were distributed into three 
treatments named Tr1, Tr2 and Tr3 to receive 1, 2, 
and 3mg kg-1 doses of tramadol IV, respectively. The 
evaluations were performed immediately before the 
IV injection and 5, 10, 20, 40, 60, 90, 120, and 180 
minutes after the application of tramadol (T0, T5, 
T10, T20, T40, T60, T90, T120, T180, respectively).
A computer was used to record and analyze 
the electrocardiogram (ECG)c. An oscillometric 
monitord was attached to a cuff on the tail of the horse 
to measure arterial blood pressure. The width of the 
cuff was 25-30% of the tail circumference. 
The anterior region of the coronary band 
of the left forelimb was prepared for assessment 
of the nociceptive threshold. This was evaluated 
using a digital analgesiometer based on the von 
Frey methode.The equipment consists of a pressure 
transducer adapted with a cable to a digital counter 
with 0.1g precision which records the weight (grams 
force, gf) applied. This device includes a transducer 
arm with a force measurement capacity of 0.1 to 
1000gf (0.98mN to 9.81N). Mechanical threshold 
were made by the same operator, who blinded to the 
actual readings obtained.
For the basal values, it was calculated the 
arithmetic mean of three measurements performed 
at 10-minute intervals. It was measured heart rate 
from the ECG (HR – beats minute-1); and respiratory 
rate (fR– breaths minute-1) by counting the chest 
movements over 1 minute. The systolic arterial 
pressure (SAP), diastolic arterial pressure (DAP) and 
mean arterial pressure (MAP) were obtained from the 
noninvasive oscillometric device.
The degree of sedation was determined 
by measuring head position (HP), considering the 
distanceof nostrils in relation to the ground with 
a ruler fi xed to the stock.The baseline value of the 
head position was measured in triplicate at 10-minute 
intervals, a result of the arithmetic mean of the 
measurements. The operator recorded the measure 
at a minimal distance of 3 meters from the animal 
using a measuring tape tied to the stock, aiming 
not to provoke any stimulus. As the animals were 
conditioned to the management, a few minutes 
after being restrained in the stock they seemed calm 
without abrupt movements with the head. If there 
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were discrepant values due to some unexpected 
reaction of the animal, new measurements were 
taken. The results were converted to percentages to 
avoid the variability caused by the size differences 
between the horses (RINGER et al., 2012). 
Gastrointestinal motility (GI) was 
evaluated by auscultation using a modifi cation of 
the method described by SINGH et al. (1997). Four 
abdominal quadrants (upper and lower on the left and 
right sides) were ausculted for at least 30 seconds (60 
seconds in the case of low frequency) at two sites per 
quadrant by one person who was not aware of the 
treatment administered to each horse.
The mechanical nociceptive threshold 
(MNT) was defi ned as the lowest force of mechanical 
stimulation that produced a response. The MNT, in 
grams-force, was measured by determining the force 
applied to the coronary band until the stimulated limb 
was lifted off the ground. Positive responses were 
shoulder and withdrawal of the left foot.A simple 
withdrawal refl ex upon fi rst touch to the skin was not 
accepted as an end point. To minimize the variations 
between the measurements, fi ve evaluations were 
performed for each time, and the mean of the 3 closest 
values was then calculated. The horses had blinders on, 
so that they could not see the stimulus being applied. 
Behavioral alterations were reported descriptively. 
The data were showed as mean±standard 
deviations. The software Sigma Stat – Windows was 
employed to analyze the data. The normal data were 
submitted to the Analysis of Variance (ANOVA) for 
repeated measurements, followed by the Student-
Newman-Keuls (SNK) test for comparison of the 
intervals inside each treatment, and a one-way 
ANOVA followed by the SNK test was used for 
comparison among the treatments for each interval. 
For the data that did not have a normal distribution, 
the Kruskal Wallis’ test was used followed by the 
SNK test. The results for the GI motility scores were 
analyzed by the Kruskal Wallis’ test followed by 
SNK test. The level of signifi cance was taken at 5% 
(P<0.05).
RESULTS   AND   DISCUSSION
The detailed results for the HR, fR SAP, 
MAP and DAP are in table 1. The tramadol did not 
affect the HR, regardless of the administered dose. No 
difference were detected between the three treatments 
(P>0.05). No changes in the ECG were recorded. 
Similar results were described by DHANJAL et al. 
(2009) after evaluating the effects of cumulative 
doses of tramadol (maximum of 1.6mg kg-1) in 
horses. For doses higher than those utilized in this 
Table 1 - Mean [SD] cardiorespiratory variables of the horses treated with 1 mg kg-1 (Tr1), 2mg kg-1 (Tr2) or 3mg kg-1(Tr3) of tramadol
intravenously.
Variables Doses T0 T5 T10 T20 T40 T60 T90 T120 T150 T180
Tr1 38[9] 37[6] 37[7] 38[9] 35[5] 36[4] 35[5] 35[5] 34[4] 34[5]
Tr2 36[6] 42[14] 40[11] 41[9] 38[6] 39[10] 38[7] 38[5] 39[8] 37[6]HRBeats min-1
Tr3 36[6] 38[7] 40[5] 39[6] 38[5] 36[7] 35[4] 35[5] 35[5] 36[7]
Tr1 23[9] 29[19] 24[17] 25[11] 25[15] 33[31] 27[17] 27[13] 29[8] 31[8]
Tr2 22[6] 29[11] 24[10] 26[10] 26[8] 24[9] 21[4] 22[4] 20[4] 23[9]fRbreathsmin-1
Tr3 22[5] 36*[15] 35*[17] 35*[18] 30[14] 34*[20] 29[16] 27[14] 23[6] 21[9]
Tr1 104[5] 123*[19] 119*[16] 125*[13] 121*[20] 132*[37] 122*[18] 116*[12] 110*[14] 111*[13]
Tr2 108[8] 123*[14] 121[13] 121[20] 117[18] 115[18] 112[16] 115[21] 109[15] 112[19]
SAP
mmHg
Tr3 109[12] 121[9] 122[6] 118[16] 121[15] 115[16] 117[17] 115[15] 115[16] 117[22]
Tr1 57[4] 71*[14] 69*[9] 73*[11] 68*[10] 75*[25] 70*[13] 66*[11] 63[11] 63[10]
Tr2 61[7] 73*[13] 72[12] 68[14] 65[11] 65[12] 65[10] 63[13] 62[10] 62[12]DAPmmHg
Tr3 62[9] 73*[9] 74[4] 70[8] 67[6] 63[10] 66[12] 66[10] 62[11] 67[17]
Tr1 72[4] 89*[15] 87*[10] 91*[11] 86*[14] 94*[29] 87*[15] 82*[11] 79[11] 79[11]
Tr2 76[7] 89*[13] 88[12] 86[16] 82[13] 82[13] 81[11] 80[15] 78[12] 78[14]MAPmmHg
Tr3 77[9] 89*[8] 90*[3] 86*[8] 84*[7] 81*[12] 83[13] 83[11] 80[13] 91[13]
*Significantly (P<0.05) different from baseline data within each time. HR – Heart Rate; fR– Respiratory Rate; SAP – Systolic Arterial
Pressure; DAP – Diastolic Arterial Pressure; MAP– Mean Arterial Pressure.
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study, GIORGI et al. (2007) observed the presence of 
tachycardia in 100% of the animals that received 5mg 
kg-1 of tramadol IV.
There were no signifi cant differences in fR 
when comparing the doses of tramadol in Tr1 or Tr2. 
However, the Tr3 had a signifi cant increase in the fR 
at T5 (P=0.025) and remained above the basal values 
during the fi rst hour of evaluation (T10: P=0.032; 
T20: p=0.02; T60: P=0.04). An increase in fR was 
also described by DHANJAL et al. (2009) when 
injecting cumulative doses of tramadol intravenously 
in horses. The cause of the increase in fR remains 
unknown. However, it is believed that this increase 
may be associated with the secondary stimulation of 
the central nervous system. 
One of the animals from the Tr1 showed a 
sudden increase in the fR (from 36 to 96 breaths per 
minute) at T60. This increase was associated with 
spasmodic contractions localized on the left fl ank 
region and in synchrony with the HR, suggesting 
synchronous diaphragmatic fl utter. As reported 
by MANSMANN et al. (1974), the accentuated 
excitement may have contributed to the appearance 
of such alterations. There are no reports of 
diaphragmatic fl utter being triggered in horses by the 
administration of opioids in the literature. However, 
in human beings, the appearance of diaphragmatic 
myoclonus after the use of μ agonist opioids was 
described (LAUTERBACH et al., 1999).
Blood pressures (SAP, MAP and DAP) 
increased 5 minutes after tramadol administration at 
the three doses studied. It is believed that the increase 
in arterial pressure may be directly associated with 
the stimulation of the sympathetic activity, due to 
the modulation and re-uptake of the monoamines 
triggered by the drug, especially of noradrenalin, as 
shown by SHIN et al. (2006). However the values 
remained in the range considered normal for the 
horses. No statistical differences were found among 
the treatments (Table 1).
Interestingly, even though no statistical 
differences among the treatments were noted (P>0.05), 
the alterations in the SAP, DAP, and MAP in the Tr1 
did last longer than in the other treatments, mainly 
when compared to the 3mg kg-1 dose. This fi nding 
may be related to the dose-depressant hemodynamic 
effects triggered by the tramadol. Despite the fact that 
the mechanisms are not completely clear, it is known 
that such in vivo effects are caused by vascular, 
myocardial and nervous alterations. Whereas lower 
doses of tramadol can cause a transitory increase in 
arterial pressure with a concomitant increase in the 
noradrenalin concentrations, high doses of the drug 
can lead to vasodilatation through the production of 
nitric oxide and to effects on smooth muscle tissue, 
with a consequent decrease in arterial pressure 
(NAGAOKA et al., 2002). 
The gastrointestinal motility scores 
decreased signifi cantly in the Tr2 (T20) and persisted 
for 60 minutes [Score median baseline 11 (11/16); 
score median T20-T60: 8 (8/16)], (P<0.05).However, 
there was no statistical difference among tramadol 
treatments. The transitory decrease in the scores of 
GI motility was similar to the fi ndings described by 
DHANJAL et al. (2009), who found that after the 
administration of 1.6mg kg-1 of tramadol, there was 
a signifi cant decrease in GI motility, persisting for 40 
minutes.  In accordance with WILDER-SMITH & 
BETTIGA (1997), the interference of tramadol with 
GI motility is related to the direct infl uence of the drug 
over the myenteric plexus by the central modulation 
via opioid or by monoaminergic mechanisms. The 
mild and transitory decrease in GI motility observe 
in this study suggests the advantage of the use 
of tramadol over other opioids such as morphine 
(BOSCAN et al., 2006) in horses. 
Tramadol, regardless of the administered 
dose, did not cause any evident sedation as measured 
by a percentage difference in the head height.Using 
the same method, DHANJAL et al. (2009) also 
observed an absence of sedation, regardless of the 
dose of tramadol used. 
The administered doses of tramadol did 
not change the MNT. No signifi cant differences were 
observed among the treatments or over time when 
compared to the baseline values of each treatment 
(Figure 1).The method used to evaluate the MNT 
was based on the absence of studies using mechanical 
stimuli to evaluate the effects of tramadol in horses. 
Considering the differences in excitability of the 
nociceptors, depending on the type of stimulus, it was 
hypothesized that results different from those already 
published in other studies would be observed. The 
maximum weight applied (1000gf) was determined 
considering the no evidence of tissue injury reported 
by KUKANIC et al. (2005), using the similar 
technique in carpal pad dogs. The repeatability of 
the stimulus and the alteration in the mechanical 
threshold were some of our concerns and they are part 
of the limitations of the von Frey method. However, 
for the studies we based on papers written before 
that attest the feasibility of the technique. The choice 
of the coronary band based on the sensitivity of the 
region and easier evaluation of the withdrawal when 
pressure was exerted. Data regarding the mechanical 
threshold evaluation in palmar region in horses were 
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not reported. However, studies performed using von 
Frey fi laments on another body region were described 
as well tolerated and feasible in horses (RÉDUA et 
al., 2002; OLESKOVICZ et al., 2006).
Similar results founded in this study were 
described by DHANJAL et al. (2009) when using 
thermal stimulation to evaluate the effects of tramadol 
in horses, with no alterations in the thermal threshold. 
According to the authors, such results would be 
related to the type of nociceptive fi ber involved 
and the stimulation of A-delta fi bers by the thermal 
method was most likely unaffected by the tramadol. 
A similar argument was applied to the present study. 
The mechanical stimulation by the von Frey method, 
when used on healthy tissues, would act preferably 
on type A fi bers (LE BARS et al., 2001), and clinical 
doses of μ agonist opioids would primarily diminish 
the activity of type C fi bers (JURNA & HEINZ, 
1979). However, studies in dogs (KUKANICH et al., 
2005; KUKANICH & PAPICH, 2011) have revealed 
the nociceptive effects of μ opioid agonists in animals 
with no tissue lesions by using mechanical stimuli, 
which would support the use of the von Frey method 
in this study.
The route of administration may also 
infl uence the absence of the effects of the tramadol over 
the MNT. As opposed to the presented results, other 
studies indicate that tramadol, when administered 
by epidural injection, may have a higher analgesic 
potential in horses (NATALINI & ROBINSON; 
2000). Using the electrical stimulation method, the 
authors observed long-duration analgesia after the 
administration of a 1mg kg-1. Despite that fact, no 
pharmacokinetics studies compare the intravenous 
and the epidural methods of administration or 
associate such results with the clinical effects. 
Behavioral alterations of different 
intensities occurred in the three treatments and were 
more evident during the administration of the drug and 
even after the fi rst 20 minutes. The alterations were 
more pronounced in the Tr3. At this treatment, the 
main fi ndings were lip droop (3/7), light contractions 
of the pectoral and lumbar muscles (3/7), general 
muscular contraction (2/7), drooling (1/7), ataxia 
(1/7) and stereotyped head movements. In the other 
treatments, the main alterations were the presence of 
lip droop (Tr2: 1/7; Tr3 3/7), light contractions of the 
pectoral muscles (2/7 in each treatment) and ataxia in 
only one (1/7) Tr2 horse. 
The observed behavioral alterations agreed 
with the fi ndings of DHANJAL et al. (2009), who 
described that IV tramadol administration in horses 
did not produce the classical effects of opioids, such 
as the act of digging and roaming in circles. However, 
muscle tremors were present in all the treatments, 
similar to what was described by other authors 
who used μ opioid agonists (GIORGI et al., 2007; 
DHANJAL et al., 2009; KNYCH et al., 2013). It is 
believed that the decrease in the behavioral effects 
was due to the method of administration used in this 
Figure 1 - Global means (±SD) of the applied force (grams force -gf) in horses treated with 1, (Tr1), 
2 (Tr2) or 3mg kg-1(Tr3) of tramadol intravenously.
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study, the dilution of the drug and the increased time 
of infusion, proposed by SHILO et al. (2007). The 
adverse effects resolved by 20 minutes post tramadol 
administration, probably associated a rapid decline 
in plasma tramadol concentrations as reported by 
KNYCH et al. (2013) for similarly doses evaluated 
in this study.
It was concluded that the clinical 
alterations induced by the IV administration of 
tramadol in the doses of 1, 2 and 3mg kg-1 are light 
and transitory. However, in this model, tramadol did 
not have a mechanical antinociceptive effect at any of 
the evaluated doses.
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